M&T Bank’s Novo Nordisk NVO Stock Holding History

M&T Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Sell	31,262 -45,057	-59%	-$2.13M	﹤0.01%	789
2025 Q4	$3.88M	Sell	76,319 -2,465	-3%	-$126K	0.01%	464
2025 Q3	$4.37M	Sell	78,784 -3,854	-5%	-$226K	0.01%	410
2025 Q2	$5.7M	Sell	82,638 -168,447	-67%	-$11.5M	0.02%	382
2025 Q1	$17.4M	Sell	251,085 -128,573	-34%	-$10.6M	0.06%	217
2024 Q4	$32.7M	Sell	379,658 -10,691	-3%	-$1.16M	0.11%	157
2024 Q3	$46.5M	Sell	390,349 -2,327	-0.6%	-$310K	0.15%	120
2024 Q2	$56.1M	Buy	392,676 +266,518	+211%	+$35.3M	0.19%	110
2024 Q1	$16.2M	Sell	126,158 -7,490	-6%	-$892K	0.06%	237
2023 Q4	$13.8M	Sell	133,648 -1,320	-1%	-$131K	0.05%	265
2023 Q3	$12.3M	Sell	134,968 -1,102	-0.8%	-$97.1K	0.05%	279
2023 Q2	$11M	Sell	136,070 -1,830	-1%	-$149K	0.04%	297
2023 Q1	$11M	Sell	137,900 -7,714	-5%	-$547K	0.04%	296
2022 Q4	$9.85M	Sell	145,614 -4,090	-3%	-$240K	0.04%	303
2022 Q3	$7.46M	Sell	149,704 -5,260	-3%	-$282K	0.03%	333
2022 Q2	$8.36M	Buy	154,964 +45,498	+42%	+$2.52M	0.04%	296
2022 Q1	$6.08M	Buy	109,466 +82,706	+309%	+$4.24M	0.03%	334
2021 Q4	$1.5M	Sell	26,760 -462	-2%	-$25K	0.01%	649
2021 Q3	$1.31M	Buy	27,222 +1,398	+5%	+$67.6K	0.01%	684
2021 Q2	$1.08M	Sell	25,824 -38,162	-60%	-$1.48M	﹤0.01%	736
2021 Q1	$2.16M	Sell	63,986 -7,962	-11%	-$284K	0.01%	536
2020 Q4	$2.51M	Sell	71,948 -362	-0.5%	-$12.5K	0.01%	516
2020 Q3	$2.51M	Sell	72,310 -13,830	-16%	-$461K	0.01%	478
2020 Q2	$2.82M	Sell	86,140 -2,860	-3%	-$91.3K	0.02%	436
2020 Q1	$2.68M	Buy	89,000 +3,976	+5%	+$118K	0.02%	448
2019 Q4	$2.46M	Buy	85,024 +4,314	+5%	+$119K	0.01%	414
2019 Q3	$2.09M	Buy	80,710 +4,078	+5%	+$103K	0.01%	507
2019 Q2	$1.96M	Buy	76,632 +2,668	+4%	+$65.9K	0.01%	538
2019 Q1	$1.94M	Sell	73,964 -8,924	-11%	-$219K	0.01%	527
2018 Q4	$1.91M	Buy	82,888 +3,538	+4%	+$78.6K	0.01%	507
2018 Q3	$1.87M	Sell	79,350 -1,242	-2%	-$30.3K	0.01%	564
2018 Q2	$1.86M	Buy	80,592 +426	+0.5%	+$10.1K	0.01%	564
2018 Q1	$1.97M	Sell	80,166 -9,814	-11%	-$258K	0.01%	540
2017 Q4	$2.42M	Sell	89,980 -5,944	-6%	-$151K	0.01%	504
2017 Q3	$2.31M	Sell	95,924 -3,726	-4%	-$84.2K	0.01%	509
2017 Q2	$2.14M	Buy	99,650 +3,036	+3%	+$61.3K	0.01%	515
2017 Q1	$1.66M	Sell	96,614 -356	-0.4%	-$6.2K	0.01%	586
2016 Q4	$1.74M	Sell	96,970 -116,826	-55%	-$2.12M	0.01%	589
2016 Q3	$4.45M	Sell	213,796 -32,604	-13%	-$808K	0.03%	347
2016 Q2	$6.63M	Buy	246,400 +17,894	+8%	+$491K	0.04%	278
2016 Q1	$6.19M	Sell	228,506 -21,370	-9%	-$573K	0.04%	294
2015 Q4	$7.26M	Buy	249,876 +12,512	+5%	+$346K	0.05%	263
2015 Q3	$6.44M	Buy	237,364 +19,036	+9%	+$539K	0.04%	282
2015 Q2	$5.98M	Buy	218,328 +15,048	+7%	+$423K	0.04%	315
2015 Q1	$5.43M	Buy	203,280 +20,930	+11%	+$482K	0.03%	350
2014 Q4	$3.86M	Sell	182,350 -16,658	-8%	-$372K	0.02%	448
2014 Q3	$4.74M	Buy	199,008 +197,388	+12,184%	+$4.54M	0.03%	399
2014 Q2	$37K	Hold	1,620	–	–	﹤0.01%	764
2014 Q1	$37K	Hold	1,620	–	–	﹤0.01%	758
2013 Q4	$30K	Hold	1,620	–	–	﹤0.01%	762
2013 Q3	$27K	Buy	1,620 +720	+80%	+$12.1K	﹤0.01%	703
2013 Q2	$14K	Buy	+900	New	+$15K	﹤0.01%	790

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

M&T Bank's NVO Position: Q1 2026 in Review

M&T Bank reduced its Novo Nordisk (NVO) stake by 59% in Q1 2026, selling an estimated $2.13M and leaving 31,262 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #789.

M&T Bank first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.1M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

M&T Bank held 31,262 shares of Novo Nordisk worth $1.15M as of Q1 2026.
M&T Bank sold 45,057 Novo Nordisk shares in Q1 2026, an estimated $2.13M.
Novo Nordisk made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #789 holding.
M&T Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Novo Nordisk position peaked at $56.1M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.